SonoScape Medical Corp. (SHE: 300633)
China
· Delayed Price · Currency is CNY 31.90
-2.30 (-6.73%)
Oct 11, 2024, 3:04 PM CST
SonoScape Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,072 | 2,108 | 1,752 | 1,435 | 1,154 | 1,243 | Upgrade
|
| Other Revenue | 17.73 | 12.65 | 10.73 | 9.27 | 9.12 | 11.02 | Upgrade
|
| Revenue | 2,090 | 2,120 | 1,763 | 1,445 | 1,163 | 1,254 | Upgrade
|
| Revenue Growth (YoY) | 6.05% | 20.29% | 22.02% | 24.20% | -7.24% | 2.20% | Upgrade
|
| Cost of Revenue | 691.54 | 684.24 | 624.18 | 533.13 | 409.79 | 444.36 | Upgrade
|
| Gross Profit | 1,398 | 1,436 | 1,138 | 911.46 | 753.3 | 809.5 | Upgrade
|
| Selling, General & Admin | 715.92 | 652.69 | 521.16 | 457.37 | 399.54 | 480.33 | Upgrade
|
| Research & Development | 426.64 | 384.26 | 328.96 | 263.06 | 237.42 | 254.91 | Upgrade
|
| Other Operating Expenses | -41.94 | -46.56 | -52.56 | -35.46 | -36.09 | -29.39 | Upgrade
|
| Operating Expenses | 1,110 | 1,005 | 817.47 | 695.26 | 610.93 | 712.13 | Upgrade
|
| Operating Income | 288.19 | 431.29 | 320.99 | 216.21 | 142.37 | 97.36 | Upgrade
|
| Interest Expense | -4.09 | -5.05 | -3.7 | -5.55 | -17.54 | -16.18 | Upgrade
|
| Interest & Investment Income | 48.2 | 46.67 | 27.09 | 17.67 | 26.44 | 15.82 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.62 | 6.84 | 17.97 | -7.05 | -14.17 | 5.33 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.73 | -3.77 | -2.21 | 37.65 | -2.47 | -1.6 | Upgrade
|
| EBT Excluding Unusual Items | 326.96 | 475.96 | 360.14 | 258.92 | 134.62 | 100.73 | Upgrade
|
| Impairment of Goodwill | -15.44 | -15.44 | - | -36.98 | -206.56 | -20.08 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.29 | -12.84 | -3.93 | 3.17 | 3.52 | 0.19 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | 0.02 | -0.74 | -0.19 | - | - | Upgrade
|
| Asset Writedown | -1.31 | -0.79 | -0.59 | -0.36 | -5.7 | -0.13 | Upgrade
|
| Other Unusual Items | 46.07 | 26.92 | 27.07 | 29.65 | 29.58 | 26.97 | Upgrade
|
| Pretax Income | 359.59 | 473.83 | 381.94 | 254.21 | -44.54 | 107.69 | Upgrade
|
| Income Tax Expense | 7.64 | 19.39 | 12.13 | 6.97 | 1.72 | 6.15 | Upgrade
|
| Net Income | 351.95 | 454.44 | 369.81 | 247.24 | -46.26 | 101.54 | Upgrade
|
| Net Income to Common | 351.95 | 454.44 | 369.81 | 247.24 | -46.26 | 101.54 | Upgrade
|
| Net Income Growth | -24.80% | 22.88% | 49.57% | - | - | -59.81% | Upgrade
|
| Shares Outstanding (Basic) | 430 | 429 | 430 | 399 | 386 | 406 | Upgrade
|
| Shares Outstanding (Diluted) | 434 | 433 | 430 | 399 | 386 | 406 | Upgrade
|
| Shares Change (YoY) | 0.74% | 0.65% | 7.83% | 3.44% | -5.08% | 1.29% | Upgrade
|
| EPS (Basic) | 0.82 | 1.06 | 0.86 | 0.62 | -0.12 | 0.25 | Upgrade
|
| EPS (Diluted) | 0.81 | 1.05 | 0.86 | 0.62 | -0.12 | 0.25 | Upgrade
|
| EPS Growth | -25.35% | 22.09% | 38.71% | - | - | -60.32% | Upgrade
|
| Free Cash Flow | 151.2 | 312.48 | 282.93 | 150.74 | 115.84 | 31.6 | Upgrade
|
| Free Cash Flow Per Share | 0.35 | 0.72 | 0.66 | 0.38 | 0.30 | 0.08 | Upgrade
|
| Dividend Per Share | 0.320 | 0.320 | 0.180 | 0.125 | - | 0.026 | Upgrade
|
| Dividend Growth | 77.78% | 77.78% | 44.00% | - | - | -60.00% | Upgrade
|
| Gross Margin | 66.91% | 67.73% | 64.59% | 63.09% | 64.77% | 64.56% | Upgrade
|
| Operating Margin | 13.79% | 20.34% | 18.21% | 14.97% | 12.24% | 7.77% | Upgrade
|
| Profit Margin | 16.84% | 21.43% | 20.98% | 17.12% | -3.98% | 8.10% | Upgrade
|
| Free Cash Flow Margin | 7.24% | 14.74% | 16.05% | 10.44% | 9.96% | 2.52% | Upgrade
|
| EBITDA | 333.64 | 478.72 | 356.61 | 247.77 | 171.25 | 122.22 | Upgrade
|
| EBITDA Margin | 15.97% | 22.58% | 20.23% | 17.15% | 14.72% | 9.75% | Upgrade
|
| D&A For EBITDA | 45.46 | 47.43 | 35.62 | 31.56 | 28.88 | 24.86 | Upgrade
|
| EBIT | 288.19 | 431.29 | 320.99 | 216.21 | 142.37 | 97.36 | Upgrade
|
| EBIT Margin | 13.79% | 20.34% | 18.21% | 14.97% | 12.24% | 7.77% | Upgrade
|
| Effective Tax Rate | 2.12% | 4.09% | 3.18% | 2.74% | - | 5.72% | Upgrade
|
| Revenue as Reported | 2,090 | 2,120 | 1,763 | 1,445 | 1,163 | 1,254 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.